Activation of Egr-1 expression in astrocytes by HIV-1 Tat: New insights into astrocyte-mediated Tat neurotoxicity

Yan Fan, Wei Zou, Linden A. Green, Byung Oh Kim, Johnny J. He

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Human immunodeficiency virus type 1 (HIV-1) Tat plays an important role in HIV-associated neuropathogenesis; the underlying mechanisms are still evolving. We have recently shown that HIV-1 Tat induces expression of glial fibrillary acidic protein (GFAP), a characteristic of HIV-1 infection of the central nervous system. We have also shown that the Tat-induced GFAP expression in astrocytes is regulated by p300 and that deletion of the early growth response 1 (Egr-1) cis-transacting element within the p300 promoter abolishes Tat-induced GFAP expression. In this study, we further examined the relationship between Tat and Egr-1 in astrocytes. We found increased Egr-1 protein expression in Tat-expressing human astrocytoma cells and mouse primary astrocytes. Using the Egr-1 promoter-driven firefly luciferase reporter gene assay and the site-directed mutagenesis, we demonstrated that Tat increased Egr-1 expression by transactivating the Egr-1 promoter and involving specific serum response elements within the promoter. Consistent with these data, we showed that Tat transactivation of the Egr-1 promoter was abrogated when astrocytes were cultured in serum-reduced media. Taken together, these results reveal that Tat directly transactivates Egr-1 expression and suggest that Tat interaction with Egr-1 is probably one of the very upstream molecular events that initiate Tat-induced astrocyte dysfunction and subsequent Tat neurotoxicity.

Original languageEnglish
Pages (from-to)121-129
Number of pages9
JournalJournal of Neuroimmune Pharmacology
Volume6
Issue number1
DOIs
StatePublished - 1 Mar 2011

Fingerprint

Astrocytes
HIV-1
Growth
Glial Fibrillary Acidic Protein
Early Growth Response Protein 1
Serum Response Element
Firefly Luciferases
Astrocytoma
Virus Diseases
Site-Directed Mutagenesis
Reporter Genes
Transcriptional Activation
Central Nervous System
HIV
Serum

Keywords

  • Egr-1
  • HIV-1 Tat
  • SRE
  • astrocytes
  • p300
  • transcription activation

Cite this

@article{0025531bc63a4f0781e46403d1a190c8,
title = "Activation of Egr-1 expression in astrocytes by HIV-1 Tat: New insights into astrocyte-mediated Tat neurotoxicity",
abstract = "Human immunodeficiency virus type 1 (HIV-1) Tat plays an important role in HIV-associated neuropathogenesis; the underlying mechanisms are still evolving. We have recently shown that HIV-1 Tat induces expression of glial fibrillary acidic protein (GFAP), a characteristic of HIV-1 infection of the central nervous system. We have also shown that the Tat-induced GFAP expression in astrocytes is regulated by p300 and that deletion of the early growth response 1 (Egr-1) cis-transacting element within the p300 promoter abolishes Tat-induced GFAP expression. In this study, we further examined the relationship between Tat and Egr-1 in astrocytes. We found increased Egr-1 protein expression in Tat-expressing human astrocytoma cells and mouse primary astrocytes. Using the Egr-1 promoter-driven firefly luciferase reporter gene assay and the site-directed mutagenesis, we demonstrated that Tat increased Egr-1 expression by transactivating the Egr-1 promoter and involving specific serum response elements within the promoter. Consistent with these data, we showed that Tat transactivation of the Egr-1 promoter was abrogated when astrocytes were cultured in serum-reduced media. Taken together, these results reveal that Tat directly transactivates Egr-1 expression and suggest that Tat interaction with Egr-1 is probably one of the very upstream molecular events that initiate Tat-induced astrocyte dysfunction and subsequent Tat neurotoxicity.",
keywords = "Egr-1, HIV-1 Tat, SRE, astrocytes, p300, transcription activation",
author = "Yan Fan and Wei Zou and Green, {Linden A.} and Kim, {Byung Oh} and He, {Johnny J.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1007/s11481-010-9217-8",
language = "English",
volume = "6",
pages = "121--129",
journal = "Journal of Neuroimmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "1",

}

Activation of Egr-1 expression in astrocytes by HIV-1 Tat : New insights into astrocyte-mediated Tat neurotoxicity. / Fan, Yan; Zou, Wei; Green, Linden A.; Kim, Byung Oh; He, Johnny J.

In: Journal of Neuroimmune Pharmacology, Vol. 6, No. 1, 01.03.2011, p. 121-129.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Activation of Egr-1 expression in astrocytes by HIV-1 Tat

T2 - New insights into astrocyte-mediated Tat neurotoxicity

AU - Fan, Yan

AU - Zou, Wei

AU - Green, Linden A.

AU - Kim, Byung Oh

AU - He, Johnny J.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Human immunodeficiency virus type 1 (HIV-1) Tat plays an important role in HIV-associated neuropathogenesis; the underlying mechanisms are still evolving. We have recently shown that HIV-1 Tat induces expression of glial fibrillary acidic protein (GFAP), a characteristic of HIV-1 infection of the central nervous system. We have also shown that the Tat-induced GFAP expression in astrocytes is regulated by p300 and that deletion of the early growth response 1 (Egr-1) cis-transacting element within the p300 promoter abolishes Tat-induced GFAP expression. In this study, we further examined the relationship between Tat and Egr-1 in astrocytes. We found increased Egr-1 protein expression in Tat-expressing human astrocytoma cells and mouse primary astrocytes. Using the Egr-1 promoter-driven firefly luciferase reporter gene assay and the site-directed mutagenesis, we demonstrated that Tat increased Egr-1 expression by transactivating the Egr-1 promoter and involving specific serum response elements within the promoter. Consistent with these data, we showed that Tat transactivation of the Egr-1 promoter was abrogated when astrocytes were cultured in serum-reduced media. Taken together, these results reveal that Tat directly transactivates Egr-1 expression and suggest that Tat interaction with Egr-1 is probably one of the very upstream molecular events that initiate Tat-induced astrocyte dysfunction and subsequent Tat neurotoxicity.

AB - Human immunodeficiency virus type 1 (HIV-1) Tat plays an important role in HIV-associated neuropathogenesis; the underlying mechanisms are still evolving. We have recently shown that HIV-1 Tat induces expression of glial fibrillary acidic protein (GFAP), a characteristic of HIV-1 infection of the central nervous system. We have also shown that the Tat-induced GFAP expression in astrocytes is regulated by p300 and that deletion of the early growth response 1 (Egr-1) cis-transacting element within the p300 promoter abolishes Tat-induced GFAP expression. In this study, we further examined the relationship between Tat and Egr-1 in astrocytes. We found increased Egr-1 protein expression in Tat-expressing human astrocytoma cells and mouse primary astrocytes. Using the Egr-1 promoter-driven firefly luciferase reporter gene assay and the site-directed mutagenesis, we demonstrated that Tat increased Egr-1 expression by transactivating the Egr-1 promoter and involving specific serum response elements within the promoter. Consistent with these data, we showed that Tat transactivation of the Egr-1 promoter was abrogated when astrocytes were cultured in serum-reduced media. Taken together, these results reveal that Tat directly transactivates Egr-1 expression and suggest that Tat interaction with Egr-1 is probably one of the very upstream molecular events that initiate Tat-induced astrocyte dysfunction and subsequent Tat neurotoxicity.

KW - Egr-1

KW - HIV-1 Tat

KW - SRE

KW - astrocytes

KW - p300

KW - transcription activation

UR - http://www.scopus.com/inward/record.url?scp=79251630527&partnerID=8YFLogxK

U2 - 10.1007/s11481-010-9217-8

DO - 10.1007/s11481-010-9217-8

M3 - Article

C2 - 20414733

AN - SCOPUS:79251630527

VL - 6

SP - 121

EP - 129

JO - Journal of Neuroimmune Pharmacology

JF - Journal of Neuroimmune Pharmacology

SN - 1557-1890

IS - 1

ER -